Intuitive Surgical (ISRG)
(Delayed Data from NSDQ)
$444.16 USD
+0.66 (0.15%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $444.23 +0.07 (0.02%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth B Momentum D VGM
Brokerage Reports
Intuitive Surgical, Inc. [ISRG]
Reports for Purchase
Showing records 201 - 220 ( 406 total )
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
Global Week Ahead: Watch Out for the Three Stooges, companies mentioned, FB, ISRG
Provider: ZACKS INVESTMENT RESEARCH
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
Significant Expansion of the Installed Base Begins to Play Out
Provider: WEDBUSH SECURITIES INC.
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
2Q17 Earnings Preview: Positive Underlying Dynamics
Provider: WEDBUSH SECURITIES INC.
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
Global Week Ahead: The Fed in the Main Circus Tent, companies mentioned- AMAT, ISRG
Provider: ZACKS INVESTMENT RESEARCH
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
Company: Intuitive Surgical, Inc.
Industry: Medical - Instruments
Analysis of da Vinci Utilization Rates and Review of 10Q Suggest Room for Further Upside; Raising PT to $875; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.